Ultralife ULBI

Ultralife FY 2023: revenue $158.6M, up 20%; diluted EPS $0.03

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Ultralife reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$158.6M+20% from $131.8M in FY 202210-K income statement, on EDGAR
  2. Net income$7.2MAgainst −$119K in FY 202210-K income statement, on EDGAR
  3. Diluted EPS$0.03Flat against $0.03 in FY 202210-K income statement, on EDGAR
  4. Cash and cash equivalents$10.2M+81% from $5.6M in FY 202210-K balance sheet, on EDGAR
  5. Cash from operations$1.9MAgainst −$1.3M in FY 202210-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when Ultralife files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3690 and related industry codes: the same peer list as the financial tables.